USPTO serial 79232007
AMIDI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BURDECKI, ANNA C
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with AMIDI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martin W. Schiffmiller
MARTIN W SCHIFFMILLER KIRSCHSTEIN ISRAEL SCHIFFMILLER & PIERON425 FIFTH AVENUE 5TH FLOORSUITE 501NEW YORK, NY 10016-2223Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, diagnostic reagents for medical and veterinary use, for medical in-vitro analysis and diagnosis in humans and animals, integrated in an electronic device, consisting of one or more chips | ABANDONED | — |
| 009 | Software, including mobile applications, for performing an in-vitro analysis and medical diagnosis in humans and animals, the storing and recording of this data and for transmitting the information recorded; computer software platforms for enabling users to operate, cluster, view, track and to research data related to health; electronic chips, namely, semiconductor chips | ABANDONED | — |
| 010 | Analysis and diagnostic devices for medical use, integrated in an electronic device, consisting of one or more chips, namely, apparatus for performing a medical in-vitro analysis and medical diagnosis in humans and animals | ABANDONED | — |
| 042 | Providing scientific and technological services and research and design relating thereto, namely, research and design in the field of in-vitro diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials; medical research and scientific study and research in scientific and biotechnological facilities, namely, research in health care with regard to the production, validation, development, storage, transport, and use of an electronic device consisting of one or more chips, integrated pharmaceutical compositions and in-vitro analysis, and diagnostic tools; designing, installing, maintaining, developing and updating software, mobile software applications and computer software platforms; consultancy and providing information regarding the aforesaid services, including provided via electronic networks such as the internet | ABANDONED | — |
| 044 | Medical services and services in the field of healthcare, namely, healthcare and providing healthcare information | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by miDiagnostics
- Other trademarks owned by miDiagnostics
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AMIDI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 8, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 23, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 18, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 26, 2020 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 5, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 23, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 26, 2019 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Aug 23, 2019 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Aug 23, 2019 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 23, 2019 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Jun 1, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 13, 2019 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 6, 2019 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| May 4, 2019 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Feb 13, 2019 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 25, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 15, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 15, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 9, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 9, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 26, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 6, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 23, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 1, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 26, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 25, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 18, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 17, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |